The Alcock Family Foundation has committed $250,000 to the Perron Institute for Neurological and Translational Science (formerly the Western Australian Neuroscience Research Institute) over the next five years, helping them to continue groundbreaking research which aims to provide a better quality of life for millions of people around the world.
The Perron Institute's Perth-based research teams have made significant breakthroughs in the research and treatment of muscle, nerve and brain conditions, with the most recent resulting in the FDA accelerated approval of a Duchenne muscular dystrophy drug available in the US. The Perron Institute is currently investigating ways to have the drug available in Australia.
To put the significance of this achievement into perspective, the research team started working on this breakthrough in 1991 and drug approvals at this level are a very rare occurence for Australian research - basically count them on one hand!
The technology also holds great promise to treat other neurological conditions such as multiple sclerosis, epilepsy, cystic fibrosis and Parkinson's.
The Perron Institute was founded in 1982, making it the state's longest established medical research institute. It recently changed its name in honour of long-time supporters Stan and Jean Perron and their family.
The Alcock Family Foundation is very proud to be able to support their cutting edge research that changes lives!